Demodex / Demodectic mange (Demodex cati, D. gatoi) in Cats

Quick Facts

🏥 Condition Name
Demodex
📋 Also Known As
Demodex / Demodectic mange (Demodex cati, D. gatoi)
📂 Category
External Parasites
📁 Subcategory
N/A
🐱 Affects
Skin, hair follicles, and sebaceous glands
🏷️ Type
Parasitic
⚠️ Severity
Mild to Moderate
💊 Treatable
Yes with medication
🔄 Contagious
D. gatoi is contagious between cats; D. cati is not
🧬 Hereditary
Genetic predisposition to immune dysfunction may increase susceptibility
🐱 Common In
Siamese, Burmese, immunocompromised cats, elderly cats

Demodex / Demodectic mange (Demodex cati, D. gatoi) Overview

Demodectic mange, commonly known as demodex, is a skin condition in cats caused by microscopic mites of the genus Demodex. Two primary species affect cats: Demodex cati, which lives within hair follicles and sebaceous glands, and Demodex gatoi, which inhabits the superficial layers of the skin. While Demodex mites are present in small numbers on many healthy cats without causing disease, clinical demodicosis develops when mite populations proliferate beyond normal levels, typically in association with immune system compromise or other underlying health conditions. The condition is relatively uncommon in cats compared to dogs but represents an important dermatological diagnosis that requires thorough investigation.

The two species of feline Demodex mites differ significantly in their characteristics and clinical implications. Demodex cati is an elongated mite that closely resembles the canine Demodex mite and is considered part of the normal skin fauna in cats, rarely causing disease except in immunocompromised individuals. Demodex gatoi is a shorter, stubbier mite that is not part of normal skin flora and is contagious between cats, potentially causing outbreaks in multicat households. Understanding which species is involved is crucial for determining appropriate treatment and management strategies, particularly regarding the need to treat in-contact cats.

Clinical demodicosis typically manifests as areas of hair loss, scaling, and crusting that may be localized to specific body regions or become generalized across large portions of the body. Demodex cati infestations often affect the face, ears, and neck, while Demodex gatoi characteristically causes intense itching and self-trauma, particularly affecting the trunk and limbs. The severity of clinical signs varies considerably depending on the extent of mite proliferation, the presence of secondary bacterial infection, and the cat's overall health status. Many cats with demodex have underlying conditions that have compromised their immune function and allowed the mite population to expand.

With appropriate diagnosis and treatment, most cats with demodectic mange can achieve resolution of their skin disease, though the prognosis depends heavily on identifying and addressing any underlying conditions. Treatment typically involves antiparasitic medications administered topically, orally, or by injection, often over several weeks to months. Cats with Demodex gatoi require particular attention to environmental management and treatment of all cats in the household to prevent reinfection. Early veterinary consultation is essential because demodicosis often signals underlying health problems that require independent investigation and management.

Causes of Demodex / Demodectic mange (Demodex cati, D. gatoi)

Demodectic mange in cats is caused by the proliferation of Demodex mites beyond the levels that the host's immune system can control. Demodex cati is a cigar-shaped mite approximately 200-300 micrometers in length that lives within hair follicles and associated sebaceous glands, feeding on sebum and cellular debris. This mite is considered part of normal skin fauna and is transmitted from mother to kitten during nursing in the first days of life. Under normal circumstances, the cat's immune system maintains mite populations at very low levels that cause no clinical disease. Clinical demodicosis develops when immune dysfunction allows unchecked mite reproduction.

Demodex gatoi is a distinctly different species characterized by its shorter, broader body shape and its habitat in the superficial stratum corneum of the skin rather than within follicles. Unlike Demodex cati, this mite is not considered normal skin flora and is contagious between cats through direct contact. Demodex gatoi can cause disease in cats with normal immune function, though immunocompromised cats may develop more severe infestations. The mite's superficial location makes it easier to transmit but also typically makes it more responsive to topical treatments than the follicular Demodex cati.

Immune system dysfunction is the primary predisposing factor for clinical Demodex cati infestations. Various conditions can compromise feline immunity and allow mite populations to expand, including feline immunodeficiency virus infection, feline leukemia virus infection, diabetes mellitus, hyperadrenocorticism, and neoplasia. Immunosuppressive medications such as corticosteroids and cyclosporine used to treat other conditions can also predispose cats to demodicosis. In many cases of feline demodicosis, thorough diagnostic investigation reveals a previously undiagnosed underlying disease that has weakened the cat's immune defenses.

Genetic factors may influence susceptibility to demodectic mange, though the inheritance patterns in cats are not as well characterized as in dogs. Certain breeds including Siamese and Burmese appear to be overrepresented among cats with demodicosis, suggesting possible breed-related immune characteristics that affect mite control. Individual genetic variations in immune function likely contribute to why some cats develop clinical disease while others with similar exposures and conditions do not. The interplay between genetic predisposition, immune status, and environmental factors determines whether mite colonization progresses to clinical disease.

Age-related factors contribute to demodicosis risk at both ends of the life spectrum. Young kittens may develop demodicosis before their immune systems are fully mature, though this is uncommon in cats compared to dogs. More frequently, demodicosis affects middle-aged to older cats in whom age-related immune decline or chronic underlying diseases have created conditions favorable for mite proliferation. The development of demodicosis in an adult cat should always prompt investigation for underlying systemic disease even when no other clinical signs are apparent.

Symptoms & Warning Signs

The earliest signs of demodectic mange are often subtle and may initially be attributed to other causes or overlooked entirely. Cats may develop small areas of thinning hair or slight scaling that progress slowly over weeks to months. Because cats are meticulous groomers, early hair loss may not be obvious if it occurs in areas the cat can easily groom. Some owners first notice increased shedding, a dull coat quality, or small patches of broken or missing hair. The cat's behavior may be entirely normal in early stages, particularly with Demodex cati infestations that typically cause minimal itching.

As demodectic mange progresses, more obvious clinical signs develop that vary depending on which Demodex species is involved. Demodex cati infestations commonly produce patchy to diffuse hair loss primarily affecting the face, ears, eyelids, and neck regions. The affected skin may appear normal initially but often develops scaling, crusting, or hyperpigmentation over time. Comedones, which appear as blackheads, may form where mites have damaged hair follicles. Secondary bacterial infection can develop, producing pustules, crusting, and more pronounced inflammation. Severe generalized cases may show extensive hair loss covering much of the body with significant skin thickening and crusting.

Demodex gatoi infestations present quite differently, with pruritus being the hallmark symptom. Affected cats experience intense itching that leads to excessive grooming, scratching, and self-induced trauma. Hair loss from Demodex gatoi typically affects the trunk, flanks, and limbs and is often characterized by a symmetrical pattern. The skin may show excoriations, broken hairs, and areas of complete alopecia from constant licking and scratching. Unlike Demodex cati, affected cats rarely show scaling or crusting unless secondary infection develops. The intense itching often leads owners to suspect allergies or other pruritic skin conditions rather than parasitic disease.

Behavioral changes accompany the physical symptoms of demodectic mange, particularly in pruritic cases. Cats with itchy infestations may become restless, irritable, and unable to rest comfortably due to constant discomfort. Sleep patterns may be disrupted as the cat repeatedly wakes to scratch or groom. Some cats develop changes in temperament, becoming less social or more easily agitated when handled. Appetite may decrease in severe cases or in cats distressed by their condition. These behavioral changes often concern owners even more than the visible skin abnormalities.

Secondary complications can produce additional symptoms beyond those caused by the mites themselves. Bacterial folliculitis and pyoderma commonly develop when damaged skin becomes infected, causing pustules, increased inflammation, pain, and sometimes fever. Severe chronic cases may develop deep skin infections with draining tracts and significant tissue damage. Ear involvement with Demodex cati can cause otitis externa with dark waxy discharge, head shaking, and ear scratching. Self-trauma from intense scratching can create open wounds susceptible to infection and further complications.

Owners should seek veterinary attention promptly when their cat shows persistent hair loss, excessive scratching or grooming, or progressive skin changes. Any cat with skin disease that is not responding to initial treatments should be evaluated for demodicosis, as this condition is often not considered initially. Multiple cats in a household developing similar itchy skin disease should raise strong suspicion for contagious Demodex gatoi. Additionally, cats diagnosed with demodicosis should receive thorough health evaluation to identify any underlying conditions that may have predisposed them to mite proliferation.

Diagnosis

Definitive diagnosis of demodectic mange requires identification of Demodex mites through microscopic examination of skin samples. The primary diagnostic technique is skin scraping, in which a scalpel blade coated with mineral oil is used to scrape the superficial layers of skin, collecting the scraped material for microscopic examination. For suspected Demodex cati, deep skin scrapings that produce slight capillary bleeding are necessary to reach the follicular mites. For Demodex gatoi, which lives more superficially, broad superficial scrapings over large areas are more effective. Multiple sites should be scraped because mite distribution may be patchy.

Microscopic examination of skin scrapings allows visualization and identification of the distinctive Demodex mites. Demodex cati appears as an elongated cigar-shaped mite with short stubby legs clustered at the anterior end, closely resembling the Demodex canis found in dogs. Demodex gatoi is noticeably shorter and broader, sometimes described as having a stubby or blunted appearance. Various life stages including eggs, larvae, nymphs, and adults may be observed in positive samples. Finding even a single Demodex gatoi mite is considered significant, while small numbers of Demodex cati may be found incidentally without causing disease, making clinical correlation essential.

Additional diagnostic techniques may be employed when skin scrapings are negative but clinical suspicion remains high. Hair pluck examination, or trichography, involves plucking hairs from affected areas and examining the roots microscopically for adherent mites. This technique is particularly useful for Demodex cati, which lives within follicles. Acetate tape preparations can detect superficial Demodex gatoi mites and are less traumatic than scraping. Fecal examination sometimes reveals Demodex mites that cats have ingested during grooming, which can be helpful when other sampling methods are negative. In rare cases, skin biopsy with histopathological examination may be necessary to identify mites within follicles.

Beyond confirming the presence of mites, comprehensive diagnostic evaluation seeks to identify underlying conditions that may have predisposed the cat to demodicosis. Baseline laboratory work including complete blood count, serum chemistry panel, and urinalysis screens for metabolic diseases and organ dysfunction. Testing for feline immunodeficiency virus and feline leukemia virus is essential in any cat with demodicosis, as these retroviruses are common underlying causes of immune compromise. Additional testing for diabetes mellitus, hyperthyroidism, or neoplasia may be indicated based on clinical findings. Identifying and treating underlying disease is crucial for successful long-term resolution of demodectic mange.

Treatment Options

Treatment of feline demodectic mange involves antiparasitic therapy to eliminate mites combined with management of any secondary infections and underlying diseases. The specific treatment protocol depends on which Demodex species is involved, the extent of the infestation, and the cat's overall health status. Treatment duration typically spans several weeks to months, with continuation required until follow-up skin scrapings are consistently negative for mites. Successful treatment requires owner commitment to the prescribed protocol and patience, as visible improvement often takes several weeks to become apparent.

Several antiparasitic medications are effective against feline Demodex mites. Lime sulfur dips applied weekly are a traditional treatment that remains effective for both Demodex species and is particularly useful for Demodex gatoi in multicat households because all cats can be treated simultaneously. Topical treatments containing selamectin, moxidectin, or fipronil may be effective for mild cases. Oral ivermectin, though not approved for use in cats, has been used effectively for feline demodicosis at carefully calculated doses. The isoxazoline class of parasiticides, including fluralaner and sarolaner, shows excellent efficacy against feline Demodex mites and has become a preferred treatment option due to convenient dosing schedules.

Systemic treatment with isoxazoline medications offers significant advantages for managing feline demodicosis. Fluralaner, administered orally or topically, provides extended activity against mites and can resolve many cases with just two to three doses given eight to twelve weeks apart. Sarolaner, given orally monthly, provides another effective option. These medications kill mites systemically after they feed on the cat's tissue fluids, eliminating mites in locations difficult to reach with topical therapies. The ease of administration and prolonged efficacy improve owner compliance and treatment success rates compared to more labor-intensive protocols.

Secondary bacterial infections require concurrent antibiotic therapy to resolve skin inflammation and promote healing. Systemic antibiotics selected based on culture and sensitivity results, or empirical broad-spectrum choices, are typically prescribed for two to four weeks or longer depending on infection severity. Topical antimicrobial treatments including medicated shampoos and ointments may supplement systemic therapy. Addressing secondary infection is essential because bacterial complications cause much of the discomfort and tissue damage associated with demodectic mange.

Management of underlying diseases is equally important as antiparasitic treatment for achieving lasting resolution of demodicosis. Cats testing positive for feline immunodeficiency virus or feline leukemia virus require appropriate management of their retroviral infection. Diabetic cats need blood glucose control optimized. Cats on immunosuppressive medications may need dosage adjustments if possible. Any concurrent illness contributing to immune compromise should be addressed. Without managing underlying conditions, mite populations may rebound after treatment cessation, leading to relapse of clinical disease.

For Demodex gatoi infestations, treatment must extend to all cats in the household regardless of whether they show clinical signs, because the mite is contagious and cats may harbor subclinical infections that serve as sources for reinfection. Environmental cleaning is not typically necessary because the mites cannot survive long off the host. However, shared bedding and grooming tools should be washed. Treatment of all cats should continue for several weeks beyond clinical resolution of the affected cat to ensure complete elimination of the mite from the household. Owners should be counseled about the potential for lengthy treatment protocols and the importance of treating all cats to achieve success.

Recovery & Prognosis

Recovery from demodectic mange typically occurs gradually over weeks to months as treatment eliminates mites and the skin heals. Early improvement signs include reduction in scaling and crusting, decreased itching in pruritic cases, and cessation of progressive hair loss. New hair growth usually becomes visible within four to six weeks of starting effective treatment, though the timeline varies depending on the extent of skin damage and the cat's overall health. Complete coat regrowth may require several months, particularly in cases with extensive hair loss or areas of significant skin scarring.

Monitoring during treatment involves regular veterinary rechecks to assess clinical improvement and perform follow-up skin scrapings. Skin scrapings are typically repeated every four to six weeks during treatment to evaluate mite burden and guide decisions about treatment duration. The goal is to achieve multiple consecutive negative skin scrapings before discontinuing treatment, as premature cessation risks relapse. Many veterinarians recommend continuing treatment for at least four weeks beyond the first negative skin scraping to ensure complete mite elimination. Cats with underlying immunocompromising conditions may require longer treatment courses or ongoing maintenance therapy.

Prognosis for demodectic mange depends significantly on the underlying cause and overall health status of the cat. Cats with localized Demodex cati infestations and no identifiable underlying disease often have excellent prognoses with complete resolution and no recurrence. Cats with generalized demodicosis secondary to FIV, FeLV, or other chronic immunosuppressive conditions face more guarded prognoses because the underlying immune dysfunction persists even after mites are eliminated. These cats may require lifelong monitoring and potentially intermittent retreatment if mite populations recur. Cats with Demodex gatoi typically have good prognoses when all cats in the household receive appropriate treatment.

Long-term outlook varies based on whether underlying predisposing factors can be corrected. Cats that developed demodicosis due to temporary immune suppression from medications or transient illness often recover completely and do not experience recurrence once the predisposing factor is resolved. Cats with permanent immune compromise from retroviral infection or chronic disease remain at elevated risk for recurrence and may need periodic monitoring even after successful treatment. Hair regrowth is usually complete unless scarring from severe or chronic infection has permanently damaged hair follicles. Overall quality of life typically returns to normal in successfully treated cats, with full restoration of coat and comfort.

Prevention

Prevention of demodectic mange focuses on maintaining overall feline health and immune function while minimizing exposure to contagious Demodex species. Since Demodex cati is considered normal skin fauna transmitted from mother to kitten, preventing initial colonization is not practical. Instead, prevention efforts aim to maintain the strong immune function necessary to keep mite populations controlled at subclinical levels. Healthy nutrition, appropriate parasite control, regular veterinary care, and minimizing stress all contribute to robust immune function and resistance to clinical demodicosis.

Preventing infection with immunosuppressive viruses significantly reduces demodicosis risk. Keeping cats indoors or in protected outdoor enclosures prevents exposure to FIV and FeLV through fights with infected cats or intimate contact with infected strays. Testing new cats before introduction to the household protects resident cats from infection. Vaccination against feline leukemia virus provides additional protection for cats with potential exposure risk. These measures protect against many health problems beyond just demodicosis, making them foundational components of responsible cat care.

Prevention of Demodex gatoi transmission requires specific measures in multicat households or catteries. New cats should ideally be quarantined and examined for skin disease before introduction to resident cats. Cats showing signs of excessive itching or unexplained hair loss should be evaluated promptly and isolated if Demodex gatoi is suspected until treatment is completed. In households where Demodex gatoi has been diagnosed, treating all cats simultaneously prevents reinfection during the treatment period. Breeders and catteries should maintain awareness of this contagious mite and implement appropriate screening and treatment protocols.

Regular veterinary examinations support early detection if demodicosis does develop, enabling prompt treatment before severe skin damage occurs. Annual wellness examinations should include skin assessment, with more frequent checks for cats with known predisposing conditions. Senior cats benefit from regular screening bloodwork that may detect underlying diseases before they advance enough to cause secondary conditions like demodicosis. Maintaining open communication with the veterinary team about any skin changes ensures prompt evaluation of potentially significant findings.

For cats with known predisposing factors for demodicosis, heightened monitoring and proactive management reduce the risk of clinical disease. Cats on long-term immunosuppressive therapy should be monitored for skin changes that might indicate mite proliferation. Diabetic cats benefit from optimal blood glucose control to support immune function. Cats with prior demodicosis should receive periodic skin examinations to detect any recurrence early. Working closely with the veterinary team to manage underlying conditions optimally provides the best protection against demodicosis and many other health problems.

Living With & Managing Demodex / Demodectic mange (Demodex cati, D. gatoi)

Daily management of a cat undergoing treatment for demodectic mange requires consistent attention to treatment protocols and supportive care. Medication administration must follow the prescribed schedule precisely, whether this involves oral medications, topical treatments, or dips. For lime sulfur dips, owners should follow preparation instructions carefully and protect themselves with gloves during application. Oral medications should be given with food if recommended to enhance absorption and reduce gastrointestinal upset. Keeping a treatment log helps track doses and ensures no treatments are missed during lengthy treatment protocols.

The home environment should support the cat's recovery and prevent reinfection in cases of contagious Demodex gatoi. While extensive environmental decontamination is not necessary because mites survive poorly off the host, washing bedding weekly in hot water removes any shed mites. In multicat households dealing with Demodex gatoi, preventing close contact between treated and untreated cats during the treatment period helps prevent reinfection. Shared grooming tools should be cleaned or replaced. The cat's living space should be comfortable and stress-free to support immune function during recovery.

Maintaining quality of life during treatment requires balancing medical management with the cat's emotional needs. Cats undergoing intensive treatment protocols may become stressed by frequent handling and medication administration. Providing positive interactions, play opportunities, and favored treats around treatment times can help reduce stress associations. If treatments cause temporary discomfort or unpleasant sensations, following them with pleasant activities helps maintain the cat's cooperative attitude. Monitoring for signs of treatment-related distress and discussing concerns with the veterinary team allows adjustment of protocols if needed.

Ongoing monitoring responsibilities continue even after visible improvement begins. Owners should observe daily for any worsening of skin lesions, new areas of hair loss, or increased scratching that might indicate treatment failure or secondary infection. Keeping scheduled veterinary appointments for skin scrapings is essential even if the cat appears clinically improved. Documentation through photographs helps track progress over time and provides useful information for veterinary visits. Any concerns about side effects from medications or unexpected changes in the cat's condition should be communicated to the veterinary team promptly.

Support for cat owners managing demodicosis cases addresses the practical and emotional aspects of treatment. Treatment protocols may span several months and require significant time investment and financial commitment. Veterinary payment plans or pet insurance can help manage costs. Connecting with other pet owners who have successfully treated demodicosis through online forums provides practical tips and emotional support. Understanding that treatment takes time and that gradual improvement is normal helps maintain realistic expectations throughout the recovery process.

Breeds at Risk for Demodex / Demodectic mange (Demodex cati, D. gatoi)

Several cat breeds appear predisposed to demodectic mange, though the condition can affect any cat when predisposing factors are present. Siamese cats are consistently overrepresented among feline demodicosis cases in multiple studies and clinical reports, suggesting possible breed-related immune characteristics that affect mite control. Burmese cats similarly appear at elevated risk for demodicosis. Both breeds are known for certain genetic health predispositions, and immune function variations may contribute to their increased susceptibility to mite proliferation. Owners of these breeds should maintain awareness of demodicosis as a potential cause of skin disease.

Other Asian breed cats including Tonkinese, which share ancestry with Siamese and Burmese, may also face elevated risk. Devon Rex and Sphynx cats have been reported with demodicosis, possibly related to their unusual coat and skin characteristics. Persian and Himalayan cats occasionally develop demodicosis, though predisposition data for these breeds is less consistent. Mixed breed cats comprise a large proportion of demodicosis cases simply due to their numerical predominance in the general cat population, though purebred cats may face higher individual risk when breed predisposition is present.

Breed predisposition should inform but not determine veterinary approach to skin disease in cats. Cats of predisposed breeds presenting with hair loss, scaling, or excessive itching warrant earlier consideration of demodicosis in the diagnostic process. However, demodicosis in any cat, regardless of breed, should prompt investigation for underlying immunosuppressive conditions because immune compromise is the primary driver of clinical disease. Breeders of predisposed breeds should maintain awareness of demodicosis in their breeding populations and work with veterinary dermatologists to understand whether affected lines might carry genetic susceptibility factors.

Related Conditions

Demodectic mange commonly occurs in association with underlying immunosuppressive conditions that enable mite proliferation. Feline immunodeficiency virus and feline leukemia virus infections are frequently identified in cats presenting with demodicosis, particularly generalized cases. Diabetes mellitus reduces immune competence and predisposes cats to various infections including demodicosis. Hyperadrenocorticism, whether naturally occurring or iatrogenic from corticosteroid therapy, suppresses immune function. Neoplasia, particularly lymphoma, may produce immune dysfunction that allows mite populations to expand. Any cat diagnosed with demodicosis should receive thorough evaluation for these and other potential underlying conditions.

Several skin conditions produce clinical signs similar to demodectic mange and must be considered in differential diagnosis. Dermatophytosis, or ringworm, causes patchy hair loss and scaling that can mimic demodicosis. Allergic skin disease including flea allergy, food allergy, and atopic dermatitis produces itching and hair loss resembling pruritic Demodex gatoi infestations. Psychogenic alopecia from overgrooming due to stress or behavioral issues creates symmetrical hair loss patterns similar to demodex. Other ectoparasites including Cheyletiella mites and lice cause scaling and hair loss. Thorough diagnostic evaluation including skin scrapings, fungal culture, and assessment for allergies ensures accurate diagnosis.

Complications and secondary conditions frequently accompany demodectic mange. Bacterial pyoderma commonly develops when mite damage to the skin barrier allows bacterial invasion, requiring antibiotic therapy alongside antiparasitic treatment. Severe chronic cases may develop deep bacterial infections with significant tissue damage. Cats that scratch intensively may create self-inflicted wounds susceptible to infection. Stress-related complications including behavioral changes and decreased appetite may occur in severely affected cats. Successful management of demodicosis requires addressing these secondary conditions along with eliminating the mites themselves.